| RS1563671108 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS1563672487 |
TMEM67
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1563673267 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS1563673490 |
TMEM67
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 3 |
| RS1563674316 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1563674576 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1563678770 |
TTPA
|
Health Risk |
Likely pathogenic |
— |
| RS1563678790 |
TTPA
|
Health Risk |
Pathogenic |
— |
| RS1563686762 |
RAD21
|
Health Risk |
Pathogenic/Likely pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS1563687901 |
RAD21
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS1563688680 |
RAD21
|
Health Risk |
Pathogenic/Likely pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS1563689416 |
RAD21
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 4, Cornelia de Lange syndrome 4 |
| RS1563697094 |
TMEM70
|
Health Risk |
Pathogenic |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
| RS1563700090 |
MNX1
|
Health Risk |
Pathogenic |
Currarino triad, Currarino triad |
| RS1563700124 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1563700205 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1563700419 |
MNX1
|
Health Risk |
Likely pathogenic |
Currarino triad, Currarino triad |
| RS1563714392 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS1563720581 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1563726973 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1563754171 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1563758564 |
VLDLR
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Cerebellar ataxia |
| RS1563764078 |
VLDLR
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1563764788 |
KCNQ3
|
Health Risk |
Pathogenic |
Benign neonatal seizures, Benign neonatal seizures |
| RS1563765580 |
RUNX1T1
|
Health Risk |
Pathogenic |
Short stature, Short stature |
| RS1563767053 |
KCNQ3
|
Health Risk |
Pathogenic |
Benign neonatal seizures, Benign neonatal seizures |
| RS1563774686 |
BNC2
|
Health Risk |
Pathogenic |
Lower Urinary Tract Obstruction, Lower urinary tract obstruction |
| RS1563793627 |
ELN
|
Health Risk |
Likely pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1563795658 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS1563796333 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS1563806122 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1563815206 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS1563818514 |
PUF60
|
Health Risk |
Pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1563819620 |
PUF60
|
Health Risk |
Pathogenic |
8q24.3 microdeletion syndrome, See cases |
| RS1563823411 |
PUF60
|
Health Risk |
Pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1563825893 |
PUF60
|
Health Risk |
Pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1563826213 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1563826453 |
PUF60
|
Health Risk |
Pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1563827503 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1563829725 |
MCM4
|
Health Risk |
Pathogenic |
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency, Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency |
| RS1563831738 |
KMT2C
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1563834980 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1563836689 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1563836857 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1563839312 |
PUF60
|
Health Risk |
Pathogenic |
— |
| RS1563840864 |
MPDZ
|
Health Risk |
Likely pathogenic |
— |
| RS1563849699 |
GLDC
|
Health Risk |
Likely pathogenic |
— |
| RS1563851439 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS1563851602 |
TYRP1
|
Health Risk |
Likely pathogenic |
Nonsyndromic Oculocutaneous Albinism, Nonsyndromic Oculocutaneous Albinism |
| RS1563856255 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS1563859767 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1563864784 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1563867837 |
CYP11B1
|
Health Risk |
Pathogenic |
Congenital adrenal hyperplasia, Deficiency of steroid 11-beta-monooxygenase |
| RS1563867899 |
CYP11B1
|
Health Risk |
Pathogenic |
— |
| RS1563869264 |
ARFGEF1
|
Health Risk |
Pathogenic |
Delayed speech and language development, Atypical behavior |
| RS1563872934 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Inborn genetic diseases |
| RS1563873580 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, EXT1-related disorder |
| RS1563886845 |
MPDZ
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1563888589 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1563888944 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial melanoma, Melanoma and neural system tumor syndrome |
| RS1563889584 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS1563889685 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS1563889847 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS1563892453 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1563892516 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1563892591 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1563892715 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS1563892769 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1563893014 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1563902635 |
CDKN2A
|
Health Risk |
risk factor |
Melanoma, cutaneous malignant |
| RS1563902931 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1563907676 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1563907686 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1563907710 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1563907859 |
RMRP
|
Health Risk |
Likely pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS1563907881 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1563907883 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1563907946 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1563908020 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Colon adenocarcinoma |
| RS1563908167 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS1563908191 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1563908212 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1563915664 |
TJP2
|
Health Risk |
Pathogenic |
— |
| RS1563919973 |
UBAP1
|
Health Risk |
Pathogenic |
Spastic paraplegia 80, autosomal dominant |
| RS1563920000 |
UBAP1
|
Health Risk |
Pathogenic |
Spastic paraplegia 80, autosomal dominant |
| RS1563920132 |
UBAP1
|
Health Risk |
Pathogenic |
Spastic paraplegia 80, autosomal dominant |
| RS1563920172 |
UBAP1
|
Health Risk |
Pathogenic |
Spastic paraplegia 80, autosomal dominant |
| RS1563920252 |
UBAP1
|
Health Risk |
Pathogenic |
Spastic paraplegia 80, autosomal dominant |
| RS1563920268 |
UBAP1
|
Health Risk |
Pathogenic |
Spastic paraplegia 80, autosomal dominant |
| RS1563921179 |
FREM1
|
Health Risk |
Pathogenic |
— |
| RS1563929039 |
TPM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Arthrogryposis, distal |
| RS1563929143 |
TPM2
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS1563929383 |
TPM2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS1563929454 |
TPM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myopathy 23, Arthrogryposis |
| RS1563930168 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS1563930321 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Sialuria, GNE myopathy |
| RS1563939611 |
VPS13A
|
Health Risk |
Pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1563939617 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS1563941569 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1563945076 |
APTX
|
Health Risk |
Pathogenic |
Ataxia, early-onset |